MacroGenics Inc. Stock
Price
Target price
€4.48
€4.48
-67.100%
-9.132
-67.100%
€17.76
14:21 / Tradegate
WKN: A1W6ND / Symbol: MGNX / Name: MacroGenics / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
MacroGenics Inc. Stock
MacroGenics Inc. took a tumble today and lost -€9.132 (-67.100%).
MacroGenics Inc. is currently one of the favorites of our community with 12 Buy predictions and no Sell predictions.
Based on the current price of 4.48 € the target price of 17 € shows a potential of 279.63% for MacroGenics Inc. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the MacroGenics Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Valuation (undervalued/overvalued)" there were negative voices in the community.
Pros and Cons of MacroGenics Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Cons
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of MacroGenics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| MacroGenics Inc. | -67.100% | -4.014% | -18.285% | 106.515% | 51.444% | -50.128% | - |
| Ardelyx Inc. | -4.600% | 19.664% | 14.204% | 98.895% | 30.761% | 36.180% | - |
| Evolus Inc | -1.650% | 2.542% | 0.000% | 47.561% | 33.702% | 64.626% | - |
| Salarius Pharmaceuticals Inc. | 2.480% | -12.174% | -6.047% | -77.430% | -27.207% | -98.343% | -99.993% |
Comments
MacroGenics, Inc. (NASDAQ: MGNX) is now covered by analysts at B. Riley. They set a "buy" rating and a $25.00 price target on the stock.
Show more
Ratings data for MGNX provided by MarketBeat
MacroGenics, Inc. (NASDAQ: MGNX) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating.
Show more
Ratings data for MGNX provided by MarketBeat
MacroGenics, Inc. (NASDAQ: MGNX) had its price target raised by analysts at Barclays PLC from $12.00 to $23.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for MGNX provided by MarketBeat
News
MacroGenics (MGNX) Q1 2024 Earnings Call Transcript
Image source: The Motley Fool.
MacroGenics (NASDAQ: MGNX)Q1 2024 Earnings CallMay 09, 2024, 4:30 p.m. ET
Operator
Source Fool.com
MacroGenics (MGNX) Q4 2023 Earnings Call Transcript
Image source: The Motley Fool.
MacroGenics (NASDAQ: MGNX)Q4 2023 Earnings CallMar 07, 2024, 4:30 p.m. ET
Operator
Source Fool.com